Depression and Anxiety: Could Magnesium Deficiency Be the Cause?
Depression and anxiety are rapidly growing global mental health concerns [1]. Interestingly, both are also frequently observed as comorbid conditions alongside neurological disorders, including migraines, epilepsy, and Parkinson’s disease [1].
The therapeutic use of magnesium in mental health is not new—it dates back as far as 1921, when it was notably used in managing cases of agitated depression [2]. Today, modern studies continue to show an inverse relationship between dietary magnesium intake and the prevalence of depression in adults [3].
Furthermore, rapid improvements in depressive symptoms have been reported with magnesium glycinate and magnesium taurate supplementation [4]. While these findings are largely based on individual case histories rather than large-scale clinical trials [4], they highlight a promising link between magnesium status and emotional health.
3 Key Ways Magnesium Supports Mental Well-Being
Magnesium plays a critical role in central nervous system function and mood regulation through three main mechanisms:
1. Essential Cofactor for Serotonin Synthesis
Magnesium acts as an essential cofactor in converting the amino acid tryptophan into serotonin—often referred to as the “feel-good” hormone. Adequate serotonin levels are key to maintaining emotional stability, resilience, and mood balance.
2. Complementary Adjunct to Standard Antidepressants [5]
A systematic review indicates that magnesium supplementation may help prevent depression and serve as a valuable adjunct to standard antidepressant therapies [5].
Intriguingly, research shows that conventional antidepressant medications—such as sertraline (150 mg/day) and amitriptyline (75 mg/day)—administered over four weeks actually increase intracellular magnesium levels [6]. This indicates that higher magnesium levels may play a key role in improving depression and anxiety outcomes.
3. Calming the Nervous System (NMDA & GABA Activity)
Magnesium acts as an NMDA receptor antagonist [7] and a GABA receptor agonist [8, 9]:
-
NMDA Inhibition [7]: By blocking overactive N-Methyl-D-aspartate (NMDA) receptors, magnesium prevents excessive excitatory signaling in the brain.
-
GABA Activation [8, 9]: By acting as a gamma-aminobutyric acid (GABA) receptor agonist, it enhances the brain’s primary calming system.
Together, these mechanisms help reduce neural hyperexcitability, lower stress levels, and promote overall mental relaxation [7, 8, 9].
Dietary Sources vs. Therapeutic Supplementation
Managing depression and anxiety typically requires a comprehensive approach, which may include therapy, medications, and lifestyle changes such as regular exercise, a nutritious diet, sufficient sleep, and effective stress management.
Nutritional support also plays a role, with magnesium being one important nutrient. While magnesium is naturally present in foods such as:
-
Green leafy vegetables
-
Legumes
-
Nuts and seeds
-
Whole grains
Achieving therapeutic levels through diet alone can be difficult. In such cases, targeted magnesium supplementation [5]—particularly in highly absorbable forms like magnesium glycinate—may help support emotional well-being as part of an overall mental health strategy.
Learn More: Discover more about Magnesium here.
Disclaimer: The information provided is for general knowledge and informational purposes only and should not be considered as medical advice or a substitute for professional consultation, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.
References
-
Institute for Health Metrics and Evaluation. (2022). Global Health Data Exchange (GHDx). https://vizhub.healthdata.org/gbd-results/ (accessed May 14, 2022)
-
Weston, P. G. (1922). Magnesium as a sedative. The American Journal of Psychiatry, 78(4), 637–638. https://doi.org/10.1176/ajp.78.4.637
-
Jacka, F., Overland, S., Stewart, R., Tell, G., Bjelland, I., & Mykletun, A. (2009). Association between magnesium intake and depression and anxiety in community-dwelling adults: The Hordaland health study. Australian and New Zealand Journal of Psychiatry, 43(1), 45–52. https://doi.org/10.1080/00048670802534408
-
Eby, G. A., & Eby, K. L. (2006). Rapid recovery from major depression using magnesium treatment. Medical Hypotheses, 67(2), 362–370. https://doi.org/10.1016/j.mehy.2006.01.047
-
Derom, M.-L., Sayón-Orea, C., Martínez-Ortega, J. M., & Martínez-González, M. A. (2013). Magnesium and depression: A systematic review. Nutritional Neuroscience, 16(5), 191–206. https://doi.org/10.1179/1476830512Y.0000000044
-
Nechifor, M. (2009). Magnesium in major depression. Magnesium Research, 22(3), 163S–166S. https://doi.org/10.1684/mrh.2009.0192
-
Murck, H. (2013). Ketamine, magnesium and major depression—from pharmacology to pathophysiology and back. Journal of Psychiatric Research, 47(7), 955–965. https://doi.org/10.1016/j.jpsychires.2013.02.015
-
Schwalfenberg, G. K., & Genuis, S. J. (2017). The Importance of Magnesium in Clinical Healthcare. Scientifica, 2017, 4179326. https://doi.org/10.1155/2017/4179326
-
Mitmesser, S. H. (2019). Micronutrient inadequacy in short sleep: Analysis of the NHANES 2005−2016. Nutrients, 11(10), 2335. https://doi.org/10.3390/nu11102335